Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $5.9500 (-1.98%) ($5.9500 - $6.0500) on Mon. Oct. 17, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.12% (three month average) | RSI | 29 | Latest Price | $5.9500(-1.98%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -1.3% a day on average for past five trading days. | Weekly Trend | CGEN declines -2.3% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) EWG(4%) TBT(4%) URA(4%) XRT(3%) DIA(2%) | Factors Impacting CGEN price | CGEN will decline at least -1.06% in a week (0% probabilities). VCSH(-8%) VCIT(-8%) USO(-8%) TIP(-7%) TAN(-7%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.06% (StdDev 2.12%) | Hourly BBV | 0 () | Intraday Trend | -1.7% | | | |
|
1 - 5 Day Possible Target | $-1.51(-125.38%) | Resistance Level | $6.34 | 5 Day Moving Average | $6.11(-2.62%) | 10 Day Moving Average | $6.15(-3.25%) | 20 Day Moving Average | $6.34(-6.15%) | To recent high | -19.7% | To recent low | 0% | Market Cap | $492m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |